Highly fragmented · Approximately $22–25 billion annually in the U.S., with Medicare funding the vast majority of hospice care expenditures

Acquire a Hospice & Palliative Care
Business

Hospice and palliative care is a Medicare-reimbursed segment of the healthcare continuum focused on comfort-oriented end-of-life care for patients with terminal diagnoses and a six-month or less prognosis. The industry is largely driven by an aging Baby Boomer population, rising chronic disease prevalence, and increasing clinical and family preference for home-based end-of-life care over hospitalization. It is heavily regulated by CMS, subject to annual Medicare reimbursement rate adjustments, and faces ongoing compliance scrutiny related to eligibility documentation, billing integrity, and referral relationships.

Who buys these: Private equity-backed healthcare platforms, regional home health and hospice roll-up operators, strategic acquirers including larger hospice chains, and occasionally high-net-worth individuals with healthcare operational experience

47×

Typical EBITDA multiple

$1M–$5M

Revenue range

Growing

Market trend

SBA Eligible

7(a) financing available

Recession Resistant

Essential service

Browse Hospice & Palliative Care Businesses for Sale →

Search live acquisition targets near you — pre-filtered to Hospice & Palliative Care

Typical Acquisition Criteria

Typically $1M–$5M revenue with $300K–$1.5M EBITDA; Medicare-certified with at least 2 years of operational history; ADC (average daily census) of 40–150 patients; clean compliance record with no active CMS investigations; diversified referral network with no single referral source exceeding 20% of admissions; licensed in states with favorable CON or non-CON environments

Get Deal Flow In Your Inbox

New Hospice & Palliative Care acquisition targets delivered weekly — free to join.

Join Free

Buyer Pain Points

  • 1Navigating complex Medicare/Medicaid certification and licensure requirements during ownership transitions
  • 2Ensuring continuity of care and retaining clinical staff including nurses, social workers, and chaplains post-acquisition
  • 3Identifying undisclosed Medicare audit exposure, overpayment risk, or RAC audit liabilities in target financials
  • 4Understanding true EBITDA margins after normalizing for owner compensation, related-party transactions, and one-time costs
  • 5Managing regulatory compliance risk including OIG scrutiny and anti-kickback statute exposure with referral sources

Common Deal Structures

  • 1Asset purchase with Medicare provider agreement novation and a 10–20% seller note or earnout tied to census retention post-close
  • 2Stock purchase retaining existing Medicare certification with escrow holdback for compliance and billing contingencies
  • 3Equity rollover deal where seller retains 10–30% ownership and partners with PE-backed platform for growth and eventual second exit

Due Diligence Focus Areas

Key items to investigate when evaluating a Hospice & Palliative Care acquisition

  • Medicare cost reports, cap calculations, and reimbursement history including any overpayment or recoupment exposure
  • Clinical compliance records including QAPI data, survey deficiencies, and any OIG or CMS enforcement actions
  • Referral source concentration, physician relationships, and anti-kickback statute compliance documentation
  • Staff licensure, turnover rates, and employment agreements for key clinical personnel including DON and Administrator
  • Payer mix analysis, ADC trends, length-of-stay data, and live discharge rates as indicators of operational quality

Competitive Moats

  • Medicare certification and state licensure creating significant regulatory barriers to entry for new competitors
  • Deep, trust-based referral relationships with physicians, hospitals, and skilled nursing facilities that take years to develop and are difficult to replicate
  • Community reputation and brand trust in end-of-life care that drives word-of-mouth referrals from families and clinicians alike

Key Industry Risks

  • Medicare reimbursement policy changes including cap adjustments, eligibility scrutiny, and payment reform initiatives that could compress margins
  • Regulatory and compliance risk including OIG enforcement, RAC audits, and heightened CMS oversight of hospice eligibility and billing practices
  • Clinical staffing shortages particularly for registered nurses and social workers in competitive labor markets driving up labor costs

EBITDA Multiple Range & Deal Economics

What buyers typically pay for Hospice & Palliative Care businesses

4×

Low Multiple

5.5×

Mid Multiple

7×

High Multiple

Hospice & Palliative Care businesses in the $1M–$5M revenue range trade at 47× EBITDA in the lower middle market. Multiple variance is driven by recurring revenue percentage, owner dependency, client concentration, and growth trajectory. Growing market conditions support multiples at or above the midpoint.

Full valuation guide for Hospice & Palliative Care

SBA Loan Eligibility

Hospice & Palliative Care acquisitions are SBA 7(a) eligible, meaning buyers can finance up to 90% of the purchase price. This expands the qualified buyer pool significantly and allows first-time acquirers to close with 10% down. Typical SBA terms run 10 years at prime + 2.75%. Sellers are often asked to carry a 5–10% note alongside SBA financing to satisfy the lender's equity requirement.

Up to 90% financed10% equity injection10-year terms available

Who Buys Hospice & Palliative Care Businesses

Typical acquirer profile for this segment

Regional hospice platform operators backed by private equity seeking geographic expansion, strategic acquirers such as large national hospice chains or home health conglomerates, and owner-operator buyers with clinical or healthcare administration backgrounds using SBA financing

Key Due Diligence Focus Areas

What to investigate before buying a Hospice & Palliative Care business

  • Medicare cost reports, cap calculations, and reimbursement history including any overpayment or recoupment exposure
  • Clinical compliance records including QAPI data, survey deficiencies, and any OIG or CMS enforcement actions
  • Referral source concentration, physician relationships, and anti-kickback statute compliance documentation
Full due diligence checklist for Hospice & Palliative Care

Seller Intelligence

Who sells Hospice & Palliative Care businesses?

Founder-operators who are nurses, physicians, or social workers that built independent hospice agencies; aging entrepreneurs seeking retirement exits after 10–20 years of operation; small regional hospice owners facing increasing regulatory complexity and reimbursement pressure

Typical exit timeline: 12–24 months

Seller page

Frequently Asked Questions

How much does a Hospice & Palliative Care business cost?

Hospice & Palliative Care businesses in the $1M–$5M revenue range typically sell for 4–7× EBITDA. Typically $1M–$5M revenue with $300K–$1.5M EBITDA; Medicare-certified with at least 2 years of operational history; ADC (average daily census) of 40–150 patients; clean compliance record with no active CMS investigations; diversified referral network with no single referral source exceeding 20% of admissions; licensed in states with favorable CON or non-CON environments

What EBITDA multiple do Hospice & Palliative Care businesses sell for?

Hospice & Palliative Care businesses typically trade at 4–7× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.

How do I buy a Hospice & Palliative Care business with an SBA loan?

Hospice & Palliative Care businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Asset purchase with Medicare provider agreement novation and a 10–20% seller note or earnout tied to census retention post-close

What should I look for when buying a Hospice & Palliative Care business?

Key due diligence areas include: Medicare cost reports, cap calculations, and reimbursement history including any overpayment or recoupment exposure; Clinical compliance records including QAPI data, survey deficiencies, and any OIG or CMS enforcement actions; Referral source concentration, physician relationships, and anti-kickback statute compliance documentation; Staff licensure, turnover rates, and employment agreements for key clinical personnel including DON and Administrator; Payer mix analysis, ADC trends, length-of-stay data, and live discharge rates as indicators of operational quality.

More Hospice & Palliative Care Guides

Related Acquisition Guides

Related Industries to Acquire

Related Searches

buy hospice agency for sale Medicare certifiedhospice business acquisition lower middle marketacquire palliative care company private equityhospice roll-up acquisition platform strategypurchase home hospice agency with existing censusMedicare certified hospice business for sale owner retiringhow to acquire a hospice company due diligencehospice agency SBA loan acquisition financingbuying hospice business compliance riskshospice company valuation multiples acquisition

Start Finding Hospice & Palliative Care Deals Today — Free to Join

DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.

Start finding deals — free

No credit card required